/NANEXA.ST
NANEXA.ST Stock - Nanexa AB (publ)
Healthcare|Drug Manufacturers - Specialty & GenericSTO
$4.21+11.98%
+$0.45 (+11.98%) • Dec 23
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.91
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.53
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $4.63
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NANEXA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.16 – $4.25
TARGET (TP)$4.84
STOP LOSS$3.87
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.68
52W High$4.22
52W Low$0.70
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $24.36M | $29.33M | $2.86M | $2.37M | $2.37M |
| Gross Profit | $46.69M | $59.16M | $3.40M | $4.31M | $20.86M |
| Gross Margin | 191.7% | 201.7% | 119.0% | 181.6% | 881.2% |
| Operating Income | $-26,062,000 | $-76,625,000 | $-57,981,000 | $-35,821,000 | $-21,489,000 |
| Net Income | $-24,905,000 | $-76,398,000 | $-58,571,000 | $-35,999,000 | $-21,736,000 |
| Net Margin | -102.2% | -260.5% | -2047.9% | -1516.4% | -918.3% |
| EPS | $-0.18 | $-1.09 | $-1.16 | $-1.01 | $-1.02 |
Company Overview
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NANEXA.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.07
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 17, 2026 | — | — | — | — |
Q4 2025 | Nov 6, 2025 | — | $-0.07 | — | — |
Q3 2025 | Aug 27, 2025 | — | $-0.03 | — | — |
Q2 2025 | May 6, 2025 | — | $-0.06 | — | — |
Q1 2025 | Feb 19, 2025 | — | $-0.09 | — | — |
Q4 2024 | Nov 7, 2024 | — | $-0.03 | — | — |
Q3 2024 | Aug 27, 2024 | — | $-0.04 | — | — |
Q2 2024 | May 3, 2024 | — | $-0.02 | — | — |
Q1 2024 | Feb 21, 2024 | — | $-0.52 | — | — |
Q4 2023 | Nov 20, 2023 | — | $-0.11 | — | — |
Q3 2023 | Aug 23, 2023 | — | $-0.16 | — | — |
Q2 2023 | May 4, 2023 | — | $-0.14 | — | — |
Q1 2023 | Feb 16, 2023 | — | $-0.35 | — | — |
Q4 2022 | Oct 25, 2022 | — | $-0.23 | — | — |
Q3 2022 | Aug 26, 2022 | — | $-0.31 | — | — |
Q2 2022 | Apr 20, 2022 | — | $-0.24 | — | — |
Q1 2022 | Feb 17, 2022 | — | $-0.31 | — | — |
Q4 2021 | Nov 10, 2021 | — | $-0.16 | — | — |
Q3 2021 | Aug 20, 2021 | — | $-0.28 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NANEXA.ST
What is NANEXA.ST's current stock price?
Nanexa AB (publ) (NANEXA.ST) is currently trading at $4.21 per share. The stock has moved +11.98% today.
What is the analyst price target for NANEXA.ST?
No analyst price targets are currently available for this stock.
What sector is Nanexa AB (publ) in?
Nanexa AB (publ) operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the STO exchange.
What is NANEXA.ST's market cap?
Nanexa AB (publ) has a market capitalization of $0.67 billion, making it a small-cap company.
Does NANEXA.ST pay dividends?
No, Nanexa AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACARIX.ST
Acarix AB (publ)
$0.28
Mkt Cap: $0.3B
ALZCUR.ST
AlzeCure Pharma AB (publ)
$2.08
Mkt Cap: $0.2B
BOUL.ST
Boule Diagnostics AB (publ)
$4.96
Mkt Cap: $0.2B
ELIC.ST
Elicera Therapeutics AB (publ)
$5.59
Mkt Cap: $0.3B
ERMA.ST
Enorama Pharma AB (publ)
$2.30
Mkt Cap: $0.2B
MNTC.ST
Mentice AB (publ)
$13.05
Mkt Cap: $0.4B
MOB.ST
Moberg Pharma AB (publ)
$10.04
Mkt Cap: $0.5B
PRO.ST
Promimic AB (publ)
$14.50
Mkt Cap: $0.3B
PTRK.ST
Physitrack PLC
$13.05
Mkt Cap: $0.2B
XINT.ST
Xintela AB (publ)
$0.27
Mkt Cap: $0.2B
Explore stocks similar to NANEXA.ST for comparison